ADVANCEMENTS AND CHALLENGES IN GASTRO-RETENTIVE DRUG DELIVERY SYSTEMS

This article examines the development, operation, applications, and future prospects of gastro-retentive drug delivery systems (GRDDS). GRDDS are designed to prolong the half-life of a drug in the stomach, thereby increasing its bioavailability and therapeutic efficacy, particularly for drugs absorbed in the upper gastrointestinal tract. Among the various GRDDS types whose formulation processes, methods of evaluation, and clinical uses are covered are floating, bioadhesive, swelling, and expandable systems. The review highlights the challenges of developing effective GRDDSs, such as ensuring system biocompatibility and controlling drug release characteristics. Future advancements in GRDDS technology are also being researched in an attempt to improve patient compliance and treatment outcomes.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-09-01
DOI
https://doi.org/10.5281/zenodo.13626304
Primary Topic
Drug Solubulity and Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ADVANCEMENTS AND CHALLENGES IN GASTRO-RETENTIVE DRUG DELIVERY SYSTEMS

Zenodo (CERN European Organization for Nuclear Research)
Drug Solubulity and Delivery Systems
article

ADVANCEMENTS AND CHALLENGES IN GASTRO-RETENTIVE DRUG DELIVERY SYSTEMS

article en

Abstract

This article examines the development, operation, applications, and future prospects of gastro-retentive drug delivery systems (GRDDS). GRDDS are designed to prolong the half-life of a drug in the stomach, thereby increasing its bioavailability and therapeutic efficacy, particularly for drugs absorbed in the upper gastrointestinal tract. Among the various GRDDS types whose formulation processes, methods of evaluation, and clinical uses are covered are floating, bioadhesive, swelling, and expandable systems. The review highlights the challenges of developing effective GRDDSs, such as ensuring system biocompatibility and controlling drug release characteristics. Future advancements in GRDDS technology are also being researched in an attempt to improve patient compliance and treatment outcomes.

Zenodo (CERN European Organization for Nuclear Research)
Matrix Research (United States) (US)
Openalex Percentile: Top 71%
Drug Solubulity and Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.